98H Stock Overview
PolarCool AB (publ), a medical device company, develops, markets, and sells products for sports medicine.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
PolarCool AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr0.0002 |
| 52 Week High | kr0.039 |
| 52 Week Low | kr0.0002 |
| Beta | 1.16 |
| 1 Month Change | -96.97% |
| 3 Month Change | -98.00% |
| 1 Year Change | -99.10% |
| 3 Year Change | -99.95% |
| 5 Year Change | n/a |
| Change since IPO | -99.95% |
Recent News & Updates
Recent updates
Shareholder Returns
| 98H | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -92.9% | -1.0% | 1.9% |
| 1Y | -99.1% | -5.0% | 4.6% |
Return vs Industry: 98H underperformed the German Medical Equipment industry which returned -5% over the past year.
Return vs Market: 98H underperformed the German Market which returned 4.6% over the past year.
Price Volatility
| 98H volatility | |
|---|---|
| 98H Average Weekly Movement | 585.0% |
| Medical Equipment Industry Average Movement | 4.6% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.4% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 98H's share price has been volatile over the past 3 months.
Volatility Over Time: 98H's weekly volatility has increased from 480% to 585% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | 3 | Erik Andersson | www.polarcool.se |
PolarCool AB (publ), a medical device company, develops, markets, and sells products for sports medicine. The company offers PolarCap System, a portable cooling device for the treatment of concussive and sub-concussive brain injury. It serves teams, organizations, and athletes.
PolarCool AB (publ) Fundamentals Summary
| 98H fundamental statistics | |
|---|---|
| Market cap | €524.78k |
| Earnings (TTM) | -€1.03m |
| Revenue (TTM) | €166.70k |
3.1x
P/S Ratio-0.5x
P/E RatioIs 98H overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 98H income statement (TTM) | |
|---|---|
| Revenue | kr1.95m |
| Cost of Revenue | kr118.16k |
| Gross Profit | kr1.84m |
| Other Expenses | kr13.94m |
| Earnings | -kr12.11m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 31, 2024
| Earnings per share (EPS) | -0.22 |
| Gross Margin | 93.95% |
| Net Profit Margin | -619.73% |
| Debt/Equity Ratio | 0% |
How did 98H perform over the long term?
See historical performance and comparison